Yahoo · Sep 28, 2026
Here's Why You Should Add GEHC Stock to Your Portfolio Right Now
GEHC's record backlog, strong orders and AI-enabled innovations offer growth potential, while inflation and China remain key risks.
NE
NASDAQ · NEOG
Neogen Corporation
Healthcare · Medical - Diagnostics & Research
$13.01
Down-$1.05 (-8.07%)
Updated Oct 6, 2026, 11:17 PM
SID Score
5.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.53B
- P/E ratio
- -1.47
- Dividend yield
- 0.00%
- 52-week range
- $8.16 – $14.26
- Volume
- 5.15M
- Avg. volume
- 5.04M
Price performance · NEOG
NEOG price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
NEOG closed at $13.01 after 20 trading sessions, up 9.47% for the selected period.
- Last close
- $13.01
- Period change
- +9.47%
- Period low
- $11.77
- Period high
- $13.98
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $12.02 | $13.06 | $11.98 | $13.01 | 5.15M |
| Oct 2, 2026 | $12.40 | $12.50 | $12.13 | $12.15 | 2.88M |
| Oct 1, 2026 | $12.68 | $12.815 | $12.19 | $12.24 | 2.97M |
| Sep 30, 2026 | $12.58 | $13.11 | $12.512 | $12.80 | 6.89M |
| Sep 29, 2026 | $13.74 | $13.87 | $12.71 | $12.73 | 14.82M |
| Sep 28, 2026 | $13.75 | $13.85 | $13.415 | $13.72 | 7.57M |
| Sep 25, 2026 | $13.68 | $13.86 | $13.38 | $13.76 | 5.22M |
| Sep 24, 2026 | $13.482 | $14.01 | $13.455 | $13.66 | 3.83M |
| Sep 23, 2026 | $14.21 | $14.26 | $13.495 | $13.57 | 3.68M |
| Sep 22, 2026 | $13.615 | $14.18 | $13.61 | $13.98 | 4.62M |
| Sep 21, 2026 | $13.12 | $13.72 | $12.96 | $13.61 | 4.4M |
| Sep 18, 2026 | $12.75 | $13.065 | $12.71 | $13.00 | 7.44M |
| Sep 17, 2026 | $12.75 | $13.00 | $12.61 | $12.83 | 3.58M |
| Sep 16, 2026 | $12.30 | $12.905 | $12.30 | $12.55 | 2.84M |
| Sep 15, 2026 | $11.95 | $12.365 | $11.85 | $12.25 | 3.28M |
| Sep 14, 2026 | $11.68 | $11.97 | $11.665 | $11.95 | 1.93M |
| Sep 11, 2026 | $11.94 | $11.98 | $11.68 | $11.78 | 1.67M |
| Sep 10, 2026 | $11.71 | $11.865 | $11.58 | $11.77 | 2.07M |
| Sep 9, 2026 | $12.09 | $12.18 | $11.745 | $11.92 | 6.16M |
| Sep 8, 2026 | $11.94 | $12.36 | $11.79 | $11.885 | 2.92M |
Latest NEOG news
The latest Smart Investors Daily articles mentioning NEOG.
Stock researchCompany · Overview
Company
Market Activity
Research & News
NEOG research
Overview
Company profile and research snapshot.
Company profile
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $6.50
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 30, 2026 | Guggenheim | Buy | — |
| Aug 26, 2026 | Piper Sandler | Overweight | — |
| Aug 3, 2026 | Piper Sandler | Neutral | — |
| Jan 12, 2026 | Piper Sandler | Neutral | — |
| Jan 9, 2026 | Guggenheim | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Sep 25, 2026
Neogen Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Neogen will report Q1 earnings Oct. 6, with EPS forecast at 5 cents and revenue at $208.18M; analysts recently raised ratings and targets.
Yahoo · Sep 24, 2026
Neogen (NEOG) Stock Looks Fully Valued On Its Sales Base
Neogen has delivered a sharp share price swing in a short span, and the recent run has investors asking whether the current valuation is still grounded in its sales profile. With the stock now reflecting a very different market view than a few years ago, the key issue is how that view lines up with what the business actually generates in revenue. The stock has returned 153.2% over the past year, which puts real pressure on the question of whether today’s price can be explained by its sales...
Yahoo · Sep 15, 2026
Neogen Announces First-Quarter Earnings Release Date
LANSING, Mich., September 15, 2026--Neogen® Corporation (NASDAQ: NEOG) will issue its first-quarter earnings release after the closing of the market on October 6, 2026. Executives from the company will host a webcast and conference call beginning at 4:30 p.m. Eastern time, to discuss the financial results.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
